[go: up one dir, main page]

WO1997032885B1 - Synthesis of isoimide of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer - Google Patents

Synthesis of isoimide of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer

Info

Publication number
WO1997032885B1
WO1997032885B1 PCT/US1997/003891 US9703891W WO9732885B1 WO 1997032885 B1 WO1997032885 B1 WO 1997032885B1 US 9703891 W US9703891 W US 9703891W WO 9732885 B1 WO9732885 B1 WO 9732885B1
Authority
WO
WIPO (PCT)
Prior art keywords
purpurin
imide
group
alkyl
derivative
Prior art date
Application number
PCT/US1997/003891
Other languages
French (fr)
Other versions
WO1997032885A1 (en
WO1997032885A9 (en
Filing date
Publication date
Priority claimed from US08/613,134 external-priority patent/US5770730A/en
Application filed filed Critical
Publication of WO1997032885A1 publication Critical patent/WO1997032885A1/en
Publication of WO1997032885B1 publication Critical patent/WO1997032885B1/en
Publication of WO1997032885A9 publication Critical patent/WO1997032885A9/en

Links

Abstract

Compounds having utility as light absorbing compounds, especially in the area of photodynamic therapy. Such compounds have formula (I), where z is = 0 or NR14; R14 is alkyl or substituted alkyl, R1 is an amino acid group, a polyamine group, a polyether group or OR13 where R13 is alkyl; R4 through R11 are -H, -OH, alkyl, alkylene, -OR16 where R16 is H, alkyl or aryl, or a carbonyl containing group, provided that: R4 may be taken together with R5 to form =O; R6 may be taken together with R7 to form =O; R8 may be taken together with R9 to form =O; R10 may be taken together with R11 to form =O; and R4 and R7 may together form a chemical bond and R8 and R11 may together form a chemical bond; and R12 is hydrogen or lower alkyl; provided that if one z is 0, the other z is -NR14.

Claims

AMENDED CLAIMS
[received by the International Bureau on 9 September 1997 (09 09.97), original claims 1 , 2, 9, 1 1 , 17 and 19 amended; original claims 12, 15, 16, 18, 22, 23 and 25 cancelled, remaimng claims unchanged (6 pages) |
1. A method for the manufacture of an imide derivative of purpurin comprising: reacting hexylamine with a chlorin or bacteriochlorin having a macrocycle with a six membered anhydride ring fused thereto, said macrocycle containing a and b rings which may be saturated or unsaturated at R^ to R-j^ positions of the rings and which R4 and R-±ι positions may contain at least one group selected from the group consisting of hydrogen, hydroxy, formyl, substituted and unsubstituted alkyl, alkoxy, alkenyl, aryl and aryloxy wherein carbon containing groups may be substituted with a substituent selected from carboxyl, hydroxy, phosphoro, carboxy, halo, sulfo, amino and ether, to obtain a purpurin derivative; and reacting the purpurin derivative with a carbodiimide to obtain the imide derivative of purpurin.
2. The method of Claim 1, wherein the carbodiimide is dicyclohexylcarbodiimide.
3. The method of Claim 1, wherein the imide derivative is further reacted with an alkali metal hydroxide to obtain a purpurin imide of the formula:
Figure imgf000003_0001
where R is selected from the group consisting of OMe and Asp-di¬ methyl ester and R- is selected from the group consisting of n- hexyl and tert-butyl Gly.
4. The method of Claim 1, wherein the imide derivative is further reacted with an alkali metal hydroxide to obtain a cyclic imide.
5. An imide of purpurin manufactured in accordance with the method of Claim 1.
6. An imide of purpurin manufactured in accordance with the method of Claim 2.
7. A reaction product comprising an imide of purpurin manufactured in accordance with the method of Claim 3.
8. A reaction product comprising an imide of purpurin manufactured in accordance with the method of Claim 4.
9. A compound of the formula:
Figure imgf000004_0001
40 where z is = 0 or = NR14; R- is an amino acid group, a polyamine group, a polyether group or 0R13 where R13 is alkyl; R14 is alkyl, substituted alkyl, a polyamine group, or an amino acid group; R4 through Rl λ are -H, -OH, alkyl, alkoxy, alkenyl, alkylene, aryl, or aryloxy, or a carbonyl containing group, wherein carbon containing groups may be substituted with carbonyl, hydroxy, phosphoro, carboxy, halo, sulfo, amino and ether substituents, provided that; R4 may be taken together with R5 to form =0; R6 may be taken together with R7 to form =0; R8 may be taken together with R9 to form =0; R,Q may be taken together with R-j^ to form =0; and R4 and R7 may together form a chemical bond and Rg and R1;L may together form a chemical bond; and R12 is hydrogen or lower alkyl; provided that if one z is = 0, the other z is = NR14.
10. The compound of Claim 9 wherein Rj^ and R12 are -CH3.
11. The compound of Claim 9 wherein Rg is -COCHo .
13. The compound of Claim 9 having the formula:
Figure imgf000005_0001
where R is normal alkyl of 2 through 12 carbon atoms .
41 14 . The compound of Claim 9 having the formula ;
Figure imgf000006_0001
C02Pr
where R is normal alkyl of 2 through 12 carbon atoms.
17. The compound of Claim 9 wherein R-^ is H3C02C-.
19. A method for the manufacture of an isoimide derivati- purpurin comprising reacting a purpurin of the formula:
Figure imgf000006_0002
wherein z is =0 or NR14; R-j^ is an amino acid group, a polyamine group, a polyether group or 0R13 where R13 is alkyl; R14 is alkyl, or substituted alkyl, a polyamine group, or an amino acid group; R4 through R-^ are -H, -OH, alkyl, alkoxy, alkenyl, alkylene, aryl, or aryloxy, or a carbonyl containing group, wherein carbon containing groups may be substituted with carbonyl, hydroxy, phosphoro, carboxy, halo, sulfo, amino and ether substituents provided that; R4 may be taken together with R5 to form =0; R6 may be taken together with R7 to form =0; Rg may be taken together with Rg to form =0; R10 may be taken together with R1;L to form =0; and R4 and R7 may together form a chemical bond and Rg and R-^ may together form a chemical bond; and R12 is hydrogen or lower alkyl; provided that if one z is =0, the other z is =NR14, with 1-hexylamine to open the anhydride ring followed by reaction with a carbodiimide to obtain the isoimide derivative of purpurin.
20. A method for the manufacture of purpurin imide comprising reacting the compound of Claim 9 with alkali metal hydroxide.
21. A method for the manufacture of purpurin imide comprising reacting the compound of Claim 10 with an alkali metal hydroxide.
24. A method for the manufacture of purpurin imide comprising reacting the compound of Claim 17 with an alkali metal hydroxide.
26. A method for the manufacture of purpurin imide comprising reacting the purpurin derivative from Claim 19 with alkali metal hydroxide.
27. A method for the manufacture of purpurin imide comprising reacting the purpurin derivative from Claim 19 with alkali metal hydroxide.
43 28. A method for the manufacture of an imide derivative of purpurin comprising: reacting hexylamine with a chlorin or bacteriochlorin having a macrocycle with a six membered anhydrid ring fused thereto, said macrocycle containing a and b rings which may be saturated or unsaturated at R4 to R-^ positions and which R4 to R-,-^ positions may contain at least one group selected from the group consisting of hydrogen, hydroxy, formal, substituted and unsubstituted alkyl, alkoxy, alkenyl, aryl and aryloxy, wherein carbon containing groups may be substituted with a substituent selected from carbonyl, hydroxy, phosphoro, carboxy, halo, sulfo, amino and ether, to obtain a purpurin derivative; and reacting the obtained purpurin derivative with a carbodiimide to obtain the imide derivative of purpurin.
44
PCT/US1997/003891 1996-03-08 1997-03-07 Synthesis of isoimide of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer WO1997032885A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/613,134 1996-03-08
US08/613,134 US5770730A (en) 1996-03-08 1996-03-08 Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
US08/812,029 1997-03-06

Publications (3)

Publication Number Publication Date
WO1997032885A1 WO1997032885A1 (en) 1997-09-12
WO1997032885B1 true WO1997032885B1 (en) 1997-11-06
WO1997032885A9 WO1997032885A9 (en) 1997-12-18

Family

ID=24456008

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/003891 WO1997032885A1 (en) 1996-03-08 1997-03-07 Synthesis of isoimide of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer

Country Status (2)

Country Link
US (2) US5770730A (en)
WO (1) WO1997032885A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
USRE39094E1 (en) 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
US5952366A (en) * 1996-03-08 1999-09-14 Health Research, Inc. Alkyl ether analogs of chlorins having an N-substituted imide ring
DK0945454T3 (en) * 1996-10-01 2003-10-27 Wyeth Lederle Japan Ltd Iminochlorin aspartic acid derivatives
CA2221912A1 (en) * 1997-11-21 1999-05-21 David Dolphin Photosensitizers with improved biodistribution and light-absorbing properties
DE19814405C2 (en) 1998-03-31 2000-03-02 Schastak Astrid Porphyrins and their use as photosensitizers
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
AU2412800A (en) * 1999-01-15 2000-08-01 Light Sciences Corporation Noninvasive vascular therapy
US6454789B1 (en) * 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
EP1131100B1 (en) * 1999-01-15 2003-03-12 Light Sciences Corporation Therapeutic compositions for metabolic bone disorders or bone metastases comprising a photosensitizer and a bisphosphonate
US6376483B1 (en) 1999-05-27 2002-04-23 Miravant Pharmaceuticals, Inc. Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
US6534040B2 (en) 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US7078014B2 (en) * 1999-12-23 2006-07-18 Health Research, Inc. Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US7166719B2 (en) * 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US7097826B2 (en) 1999-12-23 2006-08-29 Health Research, Inc. Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
JP2003519670A (en) * 2000-01-12 2003-06-24 ライト サイエンシーズ コーポレイション New treatments for eye diseases
US6624187B1 (en) * 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
WO2003061696A2 (en) * 2002-01-23 2003-07-31 Light Sciences Corporation Systems and methods for photodynamic therapy
US7053210B2 (en) * 2002-07-02 2006-05-30 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
US7057100B2 (en) * 2003-06-26 2006-06-06 The J.C. Robinson Seed Co. Inbred corn line W23129
MXPA06014326A (en) * 2004-06-07 2007-02-19 Yeda Res & Dev Cationic bacteriochlorophyll derivatives and uses thereof.
US7147840B2 (en) * 2004-11-24 2006-12-12 Health Research, Inc. Oxo-bacteriopyropheophorbide-a carboxylic acid and esters thereof
EP1933941A2 (en) 2005-08-25 2008-06-25 Philip R. Houle Treatment systems for delivery of sensitizer solutions
CN101980609B (en) * 2008-02-19 2016-10-19 健康研究有限公司 B-ring-reduced-D-ring-oxidized tetrapyrrole photosensitizers for photodynamic therapy and tumor imaging
US20110092961A1 (en) * 2008-08-13 2011-04-21 Searete Llc Artificial cells
GB0819594D0 (en) 2008-10-24 2008-12-03 Univ Coimbrra Process

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002962A (en) * 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5591847A (en) * 1994-05-23 1997-01-07 Health Research, Inc. Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages

Similar Documents

Publication Publication Date Title
WO1997032885B1 (en) Synthesis of isoimide of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
CA1311239C (en) Porphyrin derivatives, and their production and use
Kato et al. Facile carbon dioxide uptake by zinc (II)-tetraazacycloalkane complexes. 1. Syntheses, characterizations, and chemical properties of (monoalkyl carbonato)(tetraazacycloalkane) zinc (II) complexes
US4877872A (en) Production and use of dimers of hematoporophyrin, purpurins, chlorines and purpurin- and chlorin-complexes
US5591847A (en) Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages
Chang et al. The porphinedione structure of heme d1. Synthesis and spectral properties of model compounds of the prosthetic group of dissimilatory nitrite reductase.
NZ294203A (en) Chlorin derivatives such as isobacteriochlorin or bacteriochlorin and their preparation
Lee et al. Use of the chlorophyll derivative, purpurin-18, for syntheses of sensitizers for use in photodynamic therapy
WO1997032885A1 (en) Synthesis of isoimide of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
WO1997032885A9 (en) Synthesis of isoimide of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
Kasuga et al. Cycloaddition of carbon dioxide to propylene oxide catalysed by tetra-t-butylphthalocyaninatoaluminium (III) chloride
Tsuchida et al. Synthesis and O2-binding properties of tetraphenylporphyrinatoiron (II) derivatives bearing a proximal imidazole covalently bound at the β-pyrrolic position
Eckes et al. Sensitization of the NIR emission of Nd (III) by the α4 atropoisomer of a meso-tetraphenyl porphyrin bearing four 8-hydroxyquinolinylamide chelates
Sun et al. Iron-promoted nitrene-extrusion reactions in 7-azanorbornadiene derivatives
Gennari et al. Peptide bond formation using an enzyme mimicking approach
Hirota et al. TERRECYCLIC ACID A, A NEW ANTIBIOTIC FROM ASPERGILLUS TERREUS II. STRUCTURE OF TERRECYCLIC ACID A
Nemoto et al. A New Water-soluble p-Boronophenylalanine Derivative for Neutron Capture Therapy.
Bestmann et al. Enzymatic Synthesis of Chiral C4 Building Blocks from meso‐Tartaric Acid
Martin et al. Synthesis and characterization of copper (II) and nickel (II) complexes of novel 18-membered tetraaza macrocyclic ligands
Yashunsky et al. Synthesis of meso-monosubstituted ethane-and trans-ethylenebis (porphyrins)
Pearson Protonation of tricarbonyldieneiron complexes: Acid-catalysed cyclization of tricarbonylmyrceneiron
Akar et al. Synthesis of meso‐tetra acid and ester functionalized calix [4] pyrroles
Schlingmann et al. Structure of Yellow Metal‐Free and Yellow Cobalt‐Containing Corrinoids
Fuchs et al. Selective ring-opening of 3, 4, 5-tri-O-acetyl-2, 6-anhydro-D-glycero-L-manno-heptaric anhydride with ammonia: the synthesis of 7-amino-2, 6-anhydro-7-deoxy-L-glycero-L-galacto-heptonic acid
Helmreich et al. Synthesis of novel pyropheophorbide a-fullerene conjugates